Smoking and development of type 2 diabetes in patients with decreased functional capacity

International Journal of Cardiology

Volumn 104, Issue 3, 2005, Pages 275-281

  Tenenbaum, Alexander ^a,b   Fisman, Enrique Z ^a,b   Adler, Yehuda ^a,b   Motro, Michael ^a,b   Boyko, Valentina ^a   Behar, Solomon ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Coronary artery disease; Diabetes mellitus; Functional capacity; Smoking

Indexed keywords

APOLIPOPROTEIN A; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; PRIORITY JOURNAL; RISK; SAMPLE; SMOKING;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN; ISRAEL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SMOKING; TRIGLYCERIDES;

EID: 25444522599     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.10.034     Document Type: Article

References (56)

1. Diabetes Statistics National diabetes information clearinghouse NIH Publication 1999 National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 99 3926
2. K.M. Narayan, J.P. Boyle, T.J. Thompson, S.W. Sorensen, and D.F. Williamson Lifetime risk for diabetes mellitus in the United States JAMA 290 2003 1884 1890
3. S.M. Grundy, H.B. Brewer Jr., J.I. Cleeman, S.C. Smith Jr., C. Lenfant American Heart Association National Heart, Lung, and Blood Institute Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientific issues related to definition Circulation 109 2004 433 438
4. A.H. Mokdad, E.S. Ford, B.A. Bowman, F. Vinicor, J.S. Marks, and J.P. Koplan The continuing increase of diabetes in the US Diabetes Care 24 2001 412
5. T. Drivsholm, H. Ibsen, M. Schroll, M. Davidsen, and K. Borch-Johnsen Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes Diabet Med 18 2001 126 132
6. J. Shepherd Diabetes in tomorrow's world: dark clouds do have silver linings Diabetes Obes Metab 4 2002 351 355
7. C.M. Burchfiel, J.D. Curb, and B.L. Rodriguez Incidence and predictors of diabetes in Japanese-American men. The Honolulu heart program Ann Epidemiol 5 1995 33 43
8. A. von Eckardstein, H. Schulte, and G. Assmann Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster J Clin Endocrinol Metab 85 2000 3101 3108
9. L. Mykkanen, J. Kuusisto, K. Pyorala, and M. Laakso Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects Diabetologia 36 1993 553 559
10. L.L. Moore, A.J. Visioni, P.W. Wilson, R.B. D'Agostino, W.D. Finkle, and R.C. Ellison Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology 11 2000 269 273
11. E.J. Schaefer Lipoproteins, nutrition, and heart disease Am J Clin Nutr 75 2002 191 212
12. E.B. Rimm, J. Chan, M.J. Stampfer, G.A. Colditz, and W.C. Willett Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men BMJ 310 1995 555 559
13. J.E. Manson, U.A. Ajani, S. Liu, D.M. Nathan, and C.H. Hennekens A prospective study of cigarette smoking and the incidence of diabetes mellitus among US male physicians Am J Med 109 2000 538 542
14. S. Uchimoto, K. Tsumura, T. Hayashi, C. Suematsu, G. Endo, and S. Fujii Impact of cigarette smoking on the incidence of type 2 diabetes mellitus in middle-aged Japanese men: the Osaka heart survey Diabet Med 16 1999 951 955
15. I.J. Perry, S.G. Wannamethee, M.K. Walker, A.G. Thomson, P.H. Whincup, and A.G. Shaper Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men BMJ 310 1995 560 564
16. E.J. Feskens, and D. Kromhout Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen study Am J Epidemiol 130 1989 1101 1108
17. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, and J. Probstfield Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur Heart J 21 2000 1368 1375
18. L. Solang, K. Malmberg, and L. Ryden Diabetes mellitus and congestive heart failure. Further knowledge needed Eur Heart J 20 1999 789 795
19. L. Amato, G. Paolisso, F. Cacciatore, N. Ferrara, P. Ferrara, and S. Canonico Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group Diabetes Metab 23 1997 213 218
20. A. Tenenbaum, M. Motro, and E.Z. Fisman Functional class in patients with heart failure is associated with the development of diabetes Am J Med 114 2003 271 275
21. U. Goldbourt, S. Behar, H. Reicher-Reiss, J. Agmon, E. Kaplinsky, and E. Graff Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial) Am J Cardiol 71 1993 909 915
22. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study Circulation 102 2000 21 27
23. The Criteria Committee of the New York Heart Association Nomenclature and criteria for diagnosis 9th ed. 1994 Little and Brown Boston, MA
24. American Diabetes Association Report of the expert committees on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1997 1183 1197
25. S.M. Haffner, H. Miettinen, and M.P. Stern The homeostasis model in the San Antonio heart study Diabetes Care 20 1997 1087 1092
26. A. Katz, S.S. Nambi, K. Mather, A.D. Baron, D.A. Follmann, and G. Sullivan Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
27. R. Lichnovska, S. Gwozdziewiczova, and J. Hrebicek Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects Cardiovasc Diabetol 1 2002 4
28. SAS Institute Inc SAS/STAT user's guide, version 6, 4th edition vol. 2 1987 SAS Institute Press Cary, NC
29. SAS Institute Inc SAS/STAT software: changes and enhancements, release 6.07 1992 SAS Institute Press Cary, NC
30. G.A. Colditz, W.C. Willett, A. Rotnitzky, and J.E. Manson Weight gain as a risk factor for clinical diabetes mellitus in women Ann Intern Med 122 1995 481 486
31. N. Nakanishi, K. Nakamura, Y. Matsuo, K. Suzuki, and K. Tatara Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men Ann Intern Med 133 2000 183 191
32. R.H. Liu, M. Mizuta, and S. Matsukura Long-term oral nicotine administration reduces insulin resistance in obese rats Eur J Pharmacol 458 2003 227 234
33. R.J. Jarrett, and M.J. Shipley Type 2 (non-insulin-dependent diabetes) and cardiovascular disease-putative association via common antecedents; further evidence from the Whitehall study Diabetologia 31 1988 737 740
34. I.J. Perry, S.G. Wannamethee, M.K. Walker, A.G. Thomson, P.H. Whincup, and A.G. Shaper Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men Br Med J 310 1995 560 564
35. S.P. Helmrich, D.R. Ragland, R.W. Leung, and R.S. Paffenbarger Physical activity and reduced occurrence of non-insulin dependent diabetes mellitus N Engl J Med 325 1991 147 152
36. J.E. Manson, E.B. Rimm, M.J. Stampfer, G.A. Colditz, W.C. Willett, and A.S. Krolewski Physical activity and incidence of non-insulin dependent diabetes in women Lancet 338 1991 774 778
37. S. Attvall, J. Fowelin, I. Lager, H. vonSchenck, and U. Smith Smoking induces insulin resistance-a potential link with the insulin resistance syndrome J Intern Med 233 1993 327 332
38. F.S. Facchini, C.B. Hollenbeck, J.J. Jeppesen, Y.-D.I. Chen, and G.M. Reaven Insulin resistance and cigarette smoking Lancet 339 1992 1128 1130
39. T. Rönnemaa, E.M. Rönnemaa, P. Puukka, K. Pyörä lä, and M. Laakso Smoking is independently associated with high plasma insulin levels in nondiabetic men Diabetes Care 19 1996 1229 1232
40. S. Lillioja, D.M. Mott, M. Spraul, R. Ferraro, J.E. Foley, and E. Ravussin Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians N Engl J Med 329 1993 1988 1992
41. L.C. Groop Insulin resistance: the fundamental trigger of type 2 diabetes Diabetes Obes Metab 1 Suppl 1 1999 S1 S7
42. S.M. Haffner Clinical relevance of the oxidative stress concept Metabolism 49 2 Suppl 1 2000 30 34
43. M.R. Hayden, and S.C. Tyagi Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy Cardiovasc Diabetol 1 2002 3
44. B.R. Winkelmann, B.O. Boehm, M. Nauck, P. Kleist, W. Marz, and N.K. Verho Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease Curr Med Res Opin 17 2001 132 141
45. S. Sela, R. Shurtz-Swirski, J. Awad, G. Shapiro, L. Nasser, and S.M. Shasha The involvement of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation among cigarette smokers Isr Med Assoc J 4 2002 1015 1019
46. J.I. Barzilay, L. Abraham, S.R. Heckbert, M. Cushman, L.H. Kuller, and H.E. Resnick The relation of markers of inflammation to the development of glucose disorders in the elderly: the cardiovascular health study Diabetes 50 2001 2384 2389
47. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
48. D.J. Freeman, J. Norrie, M.J. Caslake, A. Gaw, I. Ford, and G.D. Lowe West of Scotland coronary prevention study. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland coronary prevention study Diabetes 51 2002 1596 1600
49. E.Z. Fisman, M. Motro, and A. Tenenbaum Cardiovascular diabetology in the core of a novel interleukins classification: the bad, the good and the aloof Cardiovasc Diabetol 2 2003 11
50. J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
51. W.G. Kuschner, A. D'Alessandro, H. Wong, and P.D. Blanc Dose-dependent cigarette smoking-related inflammatory responses in healthy adults Eur Respir J 9 1996 1989 1994
52. J.C. Will, D.A. Galuska, E.S. Ford, A. Mokdad, and E.E. Calle Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study Int J Epidemiol 30 2001 540 546
53. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker Diabetes Prevention Program Research Group Diabetes prevention program research group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
54. J.L. Chiasson, R.G. Josse, R. Gomis, M. Hanefeld, A. Karasik, M. Laakso STOP-NIDDM Trail Research Group Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Lancet 359 2002 2072 2077
55. A. Tenenbaum, M. Motro, and E.Z. Fisman Peroxisome proliferator-activated receptors ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease Circulation 109 2004 2197 2202
56. J.S. Torgerson, J. Hauptman, M.N. Boldrin, and L. Sjostrom Xenical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients Diabetes Care 27 2004 155 161